Citation Impact
Citing Papers
Osteoarthritis year in review 2019: epidemiology and therapy
2020 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Monostars: An Aid to Choosing an Antiepileptic Drug as Monotherapy
1999
Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Trial
2009
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study
2006
Early Identification of Refractory Epilepsy
2000 Standout
Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain
2003
Neurotransplantation of Fetal Porcine Cells in Patients with Basal Ganglia Infarcts: A Preliminary Safety and Feasibility Study
2005
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study
2004
Ongoing right ventricular hemodynamics in heart failure
2003
“Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews
2010
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Effects of Antiepileptic Drugs on Sleep Structure
2003
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila
2008 StandoutNobel
The New Antiepileptic Drugs
2004
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout
2007
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure
2002
Educational Guidelines for the Clinically Associated Professional in Cardiac Pacing and Electrophysiology NASPE CAP Ad Hoc Committee on Educational Guidelines
1990
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Cell transplantation for stroke
2002
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Management of Patients With Ulcer Bleeding
2012 Standout
Rheumatoid arthritis
2010 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Systematic review of non-surgical therapies for osteoarthritis of the hand: an update
2009
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
2018
Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review
2007
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Self-management education programmes for osteoarthritis
2014 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
2012 Standout
A Long-Term Follow-Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke
2010 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Simultaneous precise editing of multiple genes in human cells
2019 StandoutNobel
Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2017
Genome-wide inactivation of porcine endogenous retroviruses (PERVs)
2015 Science
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
2009
Works of Alan Moore being referenced
Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis
2007
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
1997
NO EVIDENCE FOR INFECTION OF HUMAN CELLS WITH PORCINE ENDOGENOUS RETROVIRUS (PERV) AFTER EXPOSURE TO PORCINE FETAL NEURONAL CELLS1
2000
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four‐week, multicenter, randomized, double‐blind, placebo‐controlled trial
2004
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
1997
Sensors in Pacing
1986
Initial Experience With an Implantable Hemodynamic Monitor
1996
Efficacy of Lumiracoxib in Osteoarthritis: A Review of Nine Studies
2005
Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand.
2004
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
1997